98 related articles for article (PubMed ID: 30685236)
1. Thrombotic events with proliferation signal inhibitor‒based immunosuppression in cardiac transplantation.
Witkowsky O; Teuteberg J; Althouse AD; Shullo M
J Heart Lung Transplant; 2019 Jun; 38(6):619-626. PubMed ID: 30685236
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism in heart transplant recipients: incidence, recurrence and predisposing factors.
Alvarez-Alvarez RJ; Barge-Caballero E; Chavez-Leal SA; Paniagua-Martin MJ; Marzoa-Rivas R; Caamaño CB; López-Sainz Á; Grille-Cancela Z; Blanco-Canosa P; Herrera-Noreña JM; Cuenca-Castillo JJ; Castro-Beiras A; Crespo-Leiro MG
J Heart Lung Transplant; 2015 Feb; 34(2):167-74. PubMed ID: 25434523
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus use and incidence of venous thromboembolism in cardiac transplant recipients.
Thibodeau JT; Mishkin JD; Patel PC; Kaiser PA; Ayers CR; Mammen PP; Markham DW; Ring WS; Peltz M; Drazner MH
Clin Transplant; 2012; 26(6):953-9. PubMed ID: 22775970
[TBL] [Abstract][Full Text] [Related]
4. Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review.
Salami A; Qureshi W; Kuriakose P; Moonka D; Yoshida A; Abouljoud M
Transplant Proc; 2013; 45(1):315-9. PubMed ID: 23267811
[TBL] [Abstract][Full Text] [Related]
5. Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients.
Lam NN; Garg AX; Knoll GA; Kim SJ; Lentine KL; McArthur E; Naylor KL; Bota SE; Sood MM
Am J Nephrol; 2017; 46(4):343-354. PubMed ID: 29024935
[TBL] [Abstract][Full Text] [Related]
6. Time to Event Analysis for the Development of Venous Thromboembolism After Spinal Fusion ≥ 5 Levels.
McClendon J; Smith TR; O'Shaughnessy BA; Sugrue PA; Thompson SE; Koski TR
World Neurosurg; 2015 Sep; 84(3):826-33. PubMed ID: 25871780
[TBL] [Abstract][Full Text] [Related]
7. Incidence, Risk Factors, and Outcomes of Stroke Following Cardiac Transplantation.
Alnsasra H; Asleh R; Kumar N; Lopez C; Toya T; Kremers WK; Edwards B; Daly RC; Kushwaha SS
Stroke; 2021 Nov; 52(11):e720-e724. PubMed ID: 34470491
[TBL] [Abstract][Full Text] [Related]
8. Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation.
Gonzalez-Vilchez F; Vazquez de Prada JA; Almenar L; Arizon Del Prado JM; Mirabet S; Diaz-Molina B; Delgado JF; Gomez-Bueno M; Paniagua MJ; Perez-Villa F; Roig E; Martínez-Dolz L; Brossa V; Lambert JL; Segovia J; Crespo-Leiro MG; Ruiz-Cano MJ
J Heart Lung Transplant; 2012 Mar; 31(3):288-95. PubMed ID: 22133787
[TBL] [Abstract][Full Text] [Related]
9. Hormone therapy and risk of venous thromboembolism among postmenopausal women in Taiwan - a 10-year nationwide population-based study.
Lee CH; Cheng CL; Kao Yang YH; Lin LJ
Circ J; 2015; 79(5):1107-14. PubMed ID: 25753572
[TBL] [Abstract][Full Text] [Related]
10. Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation.
González-Vílchez F; Vázquez de Prada JA; Paniagua MJ; Almenar L; Mirabet S; Gómez-Bueno M; Díaz-Molina B; Arizón JM; Delgado J; Pérez-Villa F; Crespo-Leiro MG; Martínez-Dolz L; Roig E; Segovia J; Lambert JL; Lopez-Granados A; Escribano P; Farrero M
Clin Transplant; 2013; 27(6):E649-58. PubMed ID: 24025040
[TBL] [Abstract][Full Text] [Related]
11. Renal function improvement after conversion to proliferation signal inhibitors during long-term follow-up in heart transplant recipients.
Kaplinsky E; González-Costello J; Manito N; Roca J; Barbosa MJ; Nebot M; Salazar-Mendiguchia J; Berdejo J; Mañas P; Miralles A; Cequier A
Transplant Proc; 2012 Nov; 44(9):2564-6. PubMed ID: 23146455
[TBL] [Abstract][Full Text] [Related]
12. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
[TBL] [Abstract][Full Text] [Related]
13. The occurrence of venous thromboembolism in cancer patients following major surgery.
Toledano TH; Kondal D; Kahn SR; Tagalakis V
Thromb Res; 2013 Jan; 131(1):e1-5. PubMed ID: 23174626
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and timing of venous thromboembolism after radical cystectomy in routine clinical practice: a population-based study.
Doiron RC; Booth CM; Wei X; Siemens DR
BJU Int; 2016 Nov; 118(5):714-722. PubMed ID: 26950039
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Risk Factors for Venous Thromboembolism Following Hip Arthroscopy: A Population-Based Study.
Khazi ZM; An Q; Duchman KR; Westermann RW
Arthroscopy; 2019 Aug; 35(8):2380-2384.e1. PubMed ID: 31395174
[TBL] [Abstract][Full Text] [Related]
16. The association of venous thromboembolism with blood transfusion in kidney transplant patients.
Massicotte-Azarniouch D; Sood MM; Fergusson DA; Chassé M; Tinmouth A; Knoll GA
Transfusion; 2022 Dec; 62(12):2480-2489. PubMed ID: 36325656
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study.
Cugno M; Marzano AV; Bucciarelli P; Balice Y; Cianchini G; Quaglino P; Calzavara Pinton P; Caproni M; Alaibac M; De Simone C; Patrizi A; Cozzani E; Papini M; Tedeschi A; Berti E; Rosendaal FR;
Thromb Haemost; 2016 Jan; 115(1):193-9. PubMed ID: 26245987
[TBL] [Abstract][Full Text] [Related]
18. Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin.
Nordstrom BL; Evans MA; Murphy BR; Nutescu EA; Schein JR; Bookhart BK
Curr Med Res Opin; 2015 Mar; 31(3):439-47. PubMed ID: 25495136
[TBL] [Abstract][Full Text] [Related]
19. Risk of Post-Discharge Venous Thromboembolism and Associated Mortality in General Surgery: A Population-Based Cohort Study Using Linked Hospital and Primary Care Data in England.
Bouras G; Burns EM; Howell AM; Bottle A; Athanasiou T; Darzi A
PLoS One; 2015; 10(12):e0145759. PubMed ID: 26713434
[TBL] [Abstract][Full Text] [Related]
20. The timing of venous thromboembolic events after spine surgery: a single-center experience with 6869 consecutive patients.
Cloney MB; Hopkins B; Dhillon ES; Dahdaleh NS
J Neurosurg Spine; 2018 Jan; 28(1):88-95. PubMed ID: 29125431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
